BR112022021691A2 - Moduladores de receptor de glicocorticoide (gr) para tratar um vírus sars-cov-2 - Google Patents

Moduladores de receptor de glicocorticoide (gr) para tratar um vírus sars-cov-2

Info

Publication number
BR112022021691A2
BR112022021691A2 BR112022021691A BR112022021691A BR112022021691A2 BR 112022021691 A2 BR112022021691 A2 BR 112022021691A2 BR 112022021691 A BR112022021691 A BR 112022021691A BR 112022021691 A BR112022021691 A BR 112022021691A BR 112022021691 A2 BR112022021691 A2 BR 112022021691A2
Authority
BR
Brazil
Prior art keywords
cov
sars
modulators
virus
treat
Prior art date
Application number
BR112022021691A
Other languages
English (en)
Portuguese (pt)
Inventor
Deisher Theresa
Wayne Mckay Scot
Original Assignee
Avm Biotechnology Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Avm Biotechnology Llc filed Critical Avm Biotechnology Llc
Publication of BR112022021691A2 publication Critical patent/BR112022021691A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Oncology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
BR112022021691A 2020-04-29 2021-04-28 Moduladores de receptor de glicocorticoide (gr) para tratar um vírus sars-cov-2 BR112022021691A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202063017199P 2020-04-29 2020-04-29
PCT/US2021/029608 WO2021222385A1 (en) 2020-04-29 2021-04-28 Glucocorticoid receptor (gr) modulators for treating a sars-cov-2 virus

Publications (1)

Publication Number Publication Date
BR112022021691A2 true BR112022021691A2 (pt) 2022-12-20

Family

ID=76270026

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112022021691A BR112022021691A2 (pt) 2020-04-29 2021-04-28 Moduladores de receptor de glicocorticoide (gr) para tratar um vírus sars-cov-2

Country Status (7)

Country Link
US (1) US20230172950A1 (cg-RX-API-DMAC7.html)
EP (1) EP4142736A1 (cg-RX-API-DMAC7.html)
JP (1) JP2023524434A (cg-RX-API-DMAC7.html)
KR (1) KR20230015927A (cg-RX-API-DMAC7.html)
CN (1) CN115666583A (cg-RX-API-DMAC7.html)
BR (1) BR112022021691A2 (cg-RX-API-DMAC7.html)
WO (1) WO2021222385A1 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021247000A1 (en) 2020-06-01 2021-12-09 Avm Biotechnology, Llc Methods of treatment using icam-modulating agents
EP4426317A1 (en) * 2021-11-05 2024-09-11 INSERM (Institut National de la Santé et de la Recherche Médicale) Use of low molecular weight hyaluronic acid for the treatment of lung mucosal inflammation
CN114028571B (zh) * 2021-11-18 2023-04-28 中国医学科学院基础医学研究所 含氮双膦酸盐联合糖皮质激素在预防或治疗病毒性肺炎中的应用
CN114099481B (zh) * 2022-01-28 2022-05-24 深圳湾实验室 雾化吸入型糖皮质激素纳米药物及其制备方法和应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110475571B (zh) 2017-04-01 2023-04-04 Avm生物技术有限责任公司 细胞免疫疗法前细胞毒性预调理的替代
EP3488851A1 (en) * 2018-10-03 2019-05-29 AVM Biotechnology, LLC Immunoablative therapies
KR20220148859A (ko) * 2020-02-28 2022-11-07 에이브이엠 바이오테크놀로지, 엘엘씨 림프구 집단 및 이를 생산하는 방법

Also Published As

Publication number Publication date
KR20230015927A (ko) 2023-01-31
JP2023524434A (ja) 2023-06-12
WO2021222385A1 (en) 2021-11-04
EP4142736A1 (en) 2023-03-08
US20230172950A1 (en) 2023-06-08
CN115666583A (zh) 2023-01-31

Similar Documents

Publication Publication Date Title
WO2020106642A8 (en) 2-formyl-3-hydroxyphenyloxymethyl compounds capable of modulating hemoglobin
EP4559517A3 (en) Microcurrent stimulation therapy apparatus and method
BR112021021703A2 (pt) Cicloalquilas substituídas como moduladores da via de estresse integrada
EP4491234A3 (en) Multi-specific binding proteins for activation of natural killer cells and therapeutic uses thereof to treat cancer
AR118859A1 (es) Composiciones y métodos de fabricación de células t
AU2018281308A1 (en) Methods and apparatuses for the thermal treatment of neurologic and psychiatric disorders
MX2022003193A (es) Tratamiento de encefalopatia asociada al gen syngap1.
BR112023005160A2 (pt) Terapia de combinação para o tratamento de câncer
BR112015030595A2 (pt) moduladores de receptor de estrogênio de azetidina e usos dos mesmos
BR112022026236A2 (pt) Terapia de combinação de imuno-oncologia com conjugados de il-2 e anticorpos anti-egfr
EP4035664A3 (en) Treating cancer using selective estrogen receptor modulators
BR112012007239A2 (pt) moléculas de ligação biespecíficas para terapia antiangiogênese
UA107812C2 (xx) ДВОЗАМІЩЕНІ ОКТАГІДРОПІРОЛО$3,4-с]ПІРОЛИ ЯК МОДУЛЯТОРИ ОРЕКСИНОВИХ РЕЦЕПТОРІВ
BR112018073518A2 (pt) métodos para sensibilização de células de câncer a um tratamento anticâncer, para potencialização do efeito terapêutico de um tratamento anticâncer e para tratamento de câncer, composição, modulador de canais de ânion regulados por volume, kit de peças, e, uso de um modulador de canais de ânion regulados por volume
MY178120A (en) Anti sez6 antibodies and methods of use
NO20091966L (no) Sammensetninger og fremgangsmater for a redusere proliferasjon av endometrie
SG10201806867VA (en) Dll3 modulators and methods of use
WO2010111400A3 (en) Method and kits for treating appetite suppressing disorders and disorders with an increased metabolic rate
UA111476C2 (uk) Оксазольні та ізоксазольні похідні як модулятори crac
BR112022004497A2 (pt) Administração intranasal de escetamina
BR112018002524A2 (pt) modificação em catalisadores para controlar a arquitetura polimérica
WO2016061320A3 (en) Timber therapy for post-traumatic stress disorder
BR112022021732A2 (pt) Tratamentos de câncer de próstata com combinações de acetato de abiraterona e niraparibe
BR112022010934A2 (pt) Métodos para tratar copd administrando um antagonista de il-33
BR112022025128A2 (pt) Composições e métodos para tratar doenças e distúrbios usando vesículas extracelulares microbianas de oscillospiraceae